Estrella Immunopharma Activates University Hospitals Cleveland Medical Center as Fourth Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma
Business Wire•11/08/2026•08:00 ET
0
Whiz Insights
Get started
Create a free account to read the full story.